New EAD Director Kamata Supports Making Premium for New Drug Development Permanent

September 5, 2011
Mitsuaki Kamata spoke with pharma industry reporters on August 23 at his first joint press conference since his appointment as director of the Health Policy Bureau’s Economic Affairs Division (EAD). Regarding the premium for new drug development, which the pharmaceutical...read more